Adrian B. McDermott

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 119 papers. Top paper: “Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination”.

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

New England Journal of Medicine(2020)10.1056/nejmc2032195

N/A

18.5DataRank · unranked

831 citations

Nadine Rouphael, Lisa A. Jackson, Evan J. Anderson, Paul C. Roberts, Mamodikoe Makhene +26 more

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Science(2022)10.1126/science.abm3425

N/A

17.7DataRank · unranked

1207 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng +38 more

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine(2022)10.1056/nejmoa2116414

N/A

9.7DataRank · unranked

618 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report

medRxiv(2021)10.1101/2021.10.10.21264827

N/A

5.1DataRank · unranked

98 citations

Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly +33 more

Defining the risk of SARS-CoV-2 variants on immune protection

Nature(2022)10.1038/s41586-022-04690-5

N/A

4.9DataRank · unranked

185 citations

Elodie Ghedin, Matthew B. Frieman, Florian Krammer, Alba Grifoni, Arghavan Alisoltani +95 more

Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

The Lancet(2023)10.1016/s0140-6736(22)02400-x

N/A

4.3DataRank · unranked

65 citations

Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Christine Lee, Anne Preston +50 more

Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali

New England Journal of Medicine(2022)10.1056/nejmoa2206966

N/A

3.9DataRank · unranked

127 citations

Aïssata Ongoïba, Anne C Preston, Sara A. Healy, Safiatou Doumbo, Didier Doumtabé +27 more

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial

Nature Medicine(2022)10.1038/s41591-021-01660-8

N/A

3.6DataRank · unranked

165 citations

Grace Chen, Cristina Carter, Michelle C. Crank, Thuy Nguyen, Maria Claudia Burgos Florez +70 more

Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria

New England Journal of Medicine(2022)10.1056/nejmoa2203067

N/A

3.6DataRank · unranked

125 citations

Azza H. Idris, Nina M. Berkowitz, Myra Happe, Martin R. Gaudinski, Christian Buettner +42 more

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

Nature Microbiology(2022)10.1038/s41564-022-01262-1

N/A

2.6DataRank · unranked

93 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

New England Journal of Medicine(2024)10.1056/nejmoa2312775

N/A

2.6DataRank · unranked

84 citations

Aïssata Ongoïba, Anne C Preston, Sara A. Healy, Zonghui Hu, Jeff Skinner +38 more

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Science Translational Medicine(2023)10.1126/scitranslmed.ade4790

N/A

1.9DataRank · unranked

96 citations

Amelia R. Hofstetter, Katherine V. Houser, Seemal F. Awan, Grace Chen, Maria Claudia Burgos Florez +95 more

A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies

Nature Communications(2021)10.1038/s41467-021-21954-2

N/A

1.5DataRank · unranked

89 citations

Rebecca A. Gillespie, Brian E. Fisher, Sarah F. Andrews, Julia Lederhofer, Christina Yap +10 more

A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses

Science Translational Medicine(2023)10.1126/scitranslmed.adf3309

N/A

1.4DataRank · unranked

75 citations

Stephen C. De Rosa, William J. Fulp, Allan C. deCamp, Andrew Fioré-Gartland, Celia R. Mahoney +26 more

A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination

Nature Medicine(2022)10.1038/s41591-021-01636-8

N/A

1.4DataRank · unranked

43 citations

Julie E. Raab, Jason Gorman, Rebecca A. Gillespie, Crystal S. F. Cheung, Reda Rawi +17 more

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

The Lancet Microbe(2024)10.1016/s2666-5247(23)00410-x

N/A

1.3DataRank · unranked

54 citations

Paul T. Scott, Jack N Hutter, Christine U. Lee, Melanie McCauley, Ivelese Guzman +79 more

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Science Translational Medicine(2023)10.1126/scitranslmed.ade9078

N/A

1.3DataRank · unranked

48 citations

David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly Janes, Weiping Deng +43 more

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(22)00793-9

N/A

1.2DataRank · unranked

41 citations

Andrea A. Berry, Kaitlin Mason, Azza H. Idris, Mark O’Callahan, Myra Happe +95 more

Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent Vorinostat

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab487

N/A

1.2DataRank · unranked

52 citations

Katherine S. James, Marina Tuyishime, Shane D. Falcinelli, Sarah Joseph, Matthew Moeser +18 more

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00003-6

N/A

1.1DataRank · unranked

40 citations

Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Nonhlanhla N. Mkhize, Ishana Harkoo +16 more

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

New England Journal of Medicine(2020)10.1056/nejmoa2028436

N/A

1.1DataRank · unranked

1633 citations

Nadine Rouphael, Alicia T. Widge, Lisa A. Jackson, Paul C. Roberts, Mamodikoe Makhene +32 more

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00344-4

N/A

1.0DataRank · unranked

24 citations

Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Prossy Naluyima, Francis Kiweewa +70 more

Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

Science(2021)10.1126/science.abh1766

N/A

0.807DataRank · unranked

216 citations

Tongqing Zhou, Yi Zhang, Eun Sung Yang, Chaim A. Schramm, Wei Shi +53 more

A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

Nature Medicine(2021)10.1038/s41591-021-01574-5

N/A

0.769DataRank · unranked

167 citations

Elisabeth Narayanan, Qingbo Liu, Yaroslav Tsybovsky, Kristin L. Boswell, Shilei Ding +31 more

A Global Immunological Observatory to meet a time of pandemics

eLife(2020)10.7554/elife.58989

N/A

0.685DataRank · unranked

95 citations

C. Jessica E. Metcalf, Adrian B. McDermott, Daniel C. Douek, Jeremy Farrar, Bryan T. Grenfell +1 more

Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes

Cell Reports(2023)10.1016/j.celrep.2023.112942

N/A

0.675DataRank · unranked

17 citations

Vincent Dussupt, Gina Donofrio, Gregory D. Gromowski, Rafael A. De La Barrera, Rafael A. Larocca +38 more

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

Nature Medicine(2020)10.1038/s41591-019-0746-2

N/A

0.673DataRank · unranked

88 citations

Rajeshwer S. Sankhala, Gregory D. Gromowski, Gina Donofrio, Rafael A. De La Barrera, Rafael A. Larocca +47 more

Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19

Nature(2023)10.1038/s41586-022-05670-5

N/A

0.665DataRank · unranked

83 citations

William W. Lau, Can Liu, Kyu Lee Han, Kiera L. Vrindten, Guangping Sun +30 more

Outflanking immunodominance to target subdominant broadly neutralizing epitopes

Proceedings of the National Academy of Sciences(2019)10.1073/pnas.1816300116

N/A

0.650DataRank · unranked

75 citations

Ivan Kosik, Jefferson J. S. Santos, William T. Yewdell, Carolyn M. Boudreau, Vamsee V. A. Mallajosyula +9 more

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Nature Communications(2024)10.1038/s41467-024-53727-y

N/A

0.644DataRank · unranked

21 citations

Ollivier Hyrien, Youyi Fong, David Benkeser, Sanne Roels, Daniel J Stieh +56 more

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Cell(2022)10.1016/j.cell.2022.09.032

N/A

0.637DataRank · unranked

69 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial

Nature Medicine(2024)10.1038/s41591-024-03247-5

N/A

0.628DataRank · unranked

65 citations

Victoria E. Walker-Sperling, Kshitij Wagh, Malika Aïd, Kathryn E. Stephenson, Rebecca Zash +22 more

Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1–Exposed Newborn Infants

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab229

N/A

0.598DataRank · unranked

53 citations

Coleen K. Cunningham, Petronella Muresan, Edmund V. Capparelli, Charlotte Perlowski, Patricia Morgan +44 more

Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

Immunity(2024)10.1016/j.immuni.2024.02.003

N/A

0.561DataRank · unranked

41 citations

Yaroslav Tsybovsky, Lam Nguyen, Julie E. Raab, Adrian Creanga, Tyler Stephens +14 more

Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones

Nature Communications(2022)10.1038/s41467-022-35456-2

N/A

0.561DataRank · unranked

41 citations

Maryam Musayev, Timothy S. Johnston, Danielle A. Wagner, Amy R. Henry, Lingshu Wang +51 more

Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.25.432969

N/A

0.510DataRank · unranked

29 citations

Tongqing Zhou, Yi Zhang, Eun Sung Yang, Chaim A. Schramm, Wei Shi +42 more

Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later

Immunity(2025)10.1016/j.immuni.2025.02.004

N/A

0.477DataRank · unranked

23 citations

Geoffrey D. Shimberg, Grace Mantus, Rory Malek, Lauren Y. Cominsky, Yaroslav Tsybovsky +13 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

PLoS Medicine(2024)10.1371/journal.pmed.1004329

N/A

0.438DataRank · unranked

16 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +29 more

HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide

Cell Reports(2023)10.1016/j.celrep.2023.112755

N/A

0.434DataRank · unranked

17 citations

Flavio Matassoli, Baoshan Zhang, Tracy Liu, Chen‐Hsiang Shen, Tatsiana Bylund +31 more

Structural basis for complement receptor engagement and virus neutralization through Epstein-Barr virus gp350

Immunity(2025)10.1016/j.immuni.2025.01.010

N/A

0.431DataRank · unranked

11 citations

Wei Bu, Wei‐Hung Chen, Rebecca A. Gillespie, Sarah F. Andrews, Adam K. Wheatley +14 more

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency

Scientific Reports(2022)10.1038/s41598-022-12423-x

N/A

0.416DataRank · unranked

15 citations

Nicole A. Doria‐Rose, Nicole A. Schneck, Vera B. Ivleva, Brad Tippett, William R. Shadrick +17 more

Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases

iScience(2023)10.1016/j.isci.2023.107403

N/A

0.416DataRank · unranked

15 citations

Cheng Cheng, Tongqing Zhou, Andrea Biju, Darcy R. Harris, Anita Changela +33 more

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS

JCI Insight(2024)10.1172/jci.insight.175375

N/A

0.404DataRank · unranked

7 citations

Amarendra Pegu, Larisa Strom, Cristina Carter, Cynthia S. Hendel, LaSonji A Holman +32 more

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2026

N/A

0.360DataRank · unranked

10 citations

Mina Nikanjam, Coleen K. Cunningham, Elizabeth J. McFarland, Emily E. Coates, Katherine V. Houser +10 more

Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite

Structure(2022)10.1016/j.str.2022.04.003

N/A

0.360DataRank · unranked

10 citations

Jason Gorman, Sarah F. Andrews, Reda Rawi, Mateo Reveiz, Chen‐Hsiang Shen +14 more

Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults

The Lancet HIV(2025)10.1016/s2352-3018(25)00041-4

N/A

0.335DataRank · unranked

8 citations

Katherine V. Houser, Martin R. Gaudinski, Alicia T. Widge, Seemal F. Awan, Cristina Carter +95 more

Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa

Nature Communications(2024)10.1038/s41467-024-54580-9

N/A

0.279DataRank · unranked

5 citations

Rena D. Astronomo, Yunda Huang, Sandeep Narpala, Madhu Prabhakaran, Philipp Mann +16 more

Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings

Frontiers in Immunology(2022)10.3389/fimmu.2022.1087018

N/A

0.269DataRank · unranked

5 citations

Timothy A. Watkins, Evan M. Cale, Jakob Samsel, Sarah F. Andrews, David R. Ambrozak +18 more

Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.10.012

N/A

0.269DataRank · unranked

5 citations

Kristin L. Boswell, Elizabeth Laidlaw, Brian Epling, Megan Anderson, Leonid Serebryannyy +12 more

Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine

medRxiv(2021)10.1101/2021.07.06.21259528

N/A

0.241DataRank · unranked

4 citations

Nicholas Rachmaninoff, William W. Lau, Clarisa M. Buckner, Krittin Trihemasava, Felipe Lopes de Assis +22 more

A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)

medRxiv(2024)10.1101/2024.01.10.23299799

N/A

0.208DataRank · unranked

3 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +28 more

Antibody reactivity against SARS-CoV-2 in adults from the Vancouver metropolitan area, Canada

medRxiv(2020)10.1101/2020.10.05.20206664

N/A

0.165DataRank · unranked

2 citations

Sarah O’Connell, Christina Michalski, Sarah Dada, Sandeep Narpala, Jean Gelinas +10 more

Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial

JCI Insight(2025)10.1172/jci.insight.191266

N/A

0.104DataRank · unranked

1 citations

Catriona A. Wagner, Ashley Pinckney, Jeffrey A. Cohen, Zachary S. Wallace, Arezou Khosroshahi +36 more

Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

iScience(2025)10.1016/j.isci.2025.113660

N/A

0.104DataRank · unranked

1 citations

Youyi Fong, Lars van der Laan, Fei Heng, Ying Huang, Yiwen Lu +61 more

Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine

npj Vaccines(2024)10.1038/s41541-024-00959-0

N/A

0DataRank · unranked

21 citations

Amelia R. Hofstetter, Pamela Costner, LaSonji A Holman, Cynthia S. Hendel, Alicia T. Widge +95 more

Immune memory shapes human polyclonal antibody responses to H2N2 vaccination

Cell Reports(2024)10.1016/j.celrep.2024.114171

N/A

0DataRank · unranked

8 citations

Julianna Han, Hailee R. Perrett, Sara T. Richey, Alesandra J. Rodriguez, Abigail M. Jackson +12 more

Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base

iScience(2024)10.1016/j.isci.2024.108877

N/A

0DataRank · unranked

6 citations

Angela R. Corrigan, Cheng Cheng, Andrea Biju, Christopher A. Gonelli, Adam S. Olia +25 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

UNC Libraries(2024)10.17615/jk04-ea73

N/A

0DataRank · unranked

0 citations

Carlos del Rı́o, Adrian B. McDermott, Estelle Piwowar‐Manning, Timothy Skalland, Margaret E. Ackerman +29 more

The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans

Immunity(2020)10.1016/j.immuni.2020.03.020

N/A

0DataRank · unranked

214 citations

Rebecca L. Rosenthal, James J. Knox, Arpita Myles, Martin S. Naradikian, Joanna Madej +19 more

Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies

Nature Communications(2025)10.1038/s41467-025-62339-z

N/A

0DataRank · unranked

6 citations

Andrew J. Borst, Lam Nguyen, Rebecca A. Gillespie, Connor Williams, E Walker +16 more

Dynamics of endemic virus re-emergence in children in the USA following the COVID-19 pandemic (2022–23): a prospective, multicentre, longitudinal, immunoepidemiological surveillance study

The Lancet Infectious Diseases(2025)10.1016/s1473-3099(25)00349-4

N/A

0DataRank · unranked

6 citations

Sang Woo Park, Matthew R. Vogt, Perdita Permaul, Alicen B. Spaulding, Michelle L. Hernandez +26 more

Computationally designed stem-epitope mimetics elicit broadly reactive antibodies

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.22.634229

N/A

0DataRank · unranked

0 citations

Andreas Scheck, Laura Reusch, Flavio Matassoli, Sandrine Georgeon, Karla M. Castro +16 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Improved targeting and elicitation of VRC01-class precursors by an optimized glycan-masking mutant of OD-GT8

Research Square(2025)10.21203/rs.3.rs-6941578/v1

N/A

0DataRank · unranked

0 citations

Xuejun Chen, Jeffrey C. Boyington, Madhu Prabhakaran, Sam Charaf, Katelyn Nguyen +11 more

The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody

Structure(2025)10.1016/j.str.2025.07.015

N/A

0DataRank · unranked

0 citations

Nicholas C. Morano, Crystal Sao‐Fong Cheung, Haijuan Du, Jason Gorman, Madhu Prabhakaran +17 more

Precise targeting of HIV broadly neutralizing antibody precursors in humans

Science(2025)10.1126/science.adv5572

N/A

0DataRank · unranked

43 citations

Madhu Prabhakaran, Gabriel Ozorowski, Kellie J. MacPhee, Weiwei Wu, Karlijn van der Straten +71 more

Convergent Evolution in Breadth of Two VH6-1-Encoded Influenza Antibody Clonotypes from a Single Donor

Cell Host & Microbe(2020)10.1016/j.chom.2020.06.003

N/A

0DataRank · unranked

35 citations

Sarah F. Andrews, Julie E. Raab, Sarah O’Connell, Chaim A. Schramm, Xintao Ding +10 more

Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses

Nature Communications(2020)10.1038/s41467-020-14579-4

N/A

0DataRank · unranked

56 citations

Geoffrey B. Hutchinson, Jeffrey C. Boyington, Syed M. Moin, Rebecca A. Gillespie, Yaroslav Tsybovsky +13 more

Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses

Journal of Virology(2020)10.1128/jvi.00074-20

N/A

0DataRank · unranked

33 citations

Yen‐Ting Lai, Jeffrey C. Boyington, Cheng Cheng, Hui Geng, Sandeep Narpala +21 more

Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature

Cell Reports(2020)10.1016/j.celrep.2020.107981

N/A

0DataRank · unranked

25 citations

Hongying Duan, Kai Xu, Gwo‐Yu Chuang, Angela R. Corrigan, Hui Geng +28 more

Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children

Clinical Immunology(2020)10.1016/j.clim.2020.108440

N/A

0DataRank · unranked

10 citations

Sonia Zicari, Francesca Rocchi, Lesley R. de Armas, Suresh Pallikkuth, Stefano Rinaldi +12 more

Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen

UNC Libraries(2020)10.17615/qb4q-dk73

N/A

0DataRank · unranked

4 citations

A. Schultz, G. Morrow, N. Y. Sardesai, Marı́a J. Chiuchiolo, N. Winstone +21 more

Plasmodium falciparum -specific IgM B cells dominate in children, expand with malaria and produce parasite inhibitory IgM

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.12.030049

N/A

0DataRank · unranked

4 citations

Ababacar Diouf, Kazutoyo Miura, Kristin L. Boswell, Padmapriya Sekar, Jeff Skinner +16 more

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

New England Journal of Medicine(2021)10.1056/nejmc2103916

N/A

0DataRank · unranked

758 citations

Mehul S. Suthar, Mat Makowski, Sarah O’Connell, Adrian B. McDermott, Britta Flach +25 more

Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

Science(2021)10.1126/science.abj4176

N/A

0DataRank · unranked

602 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +82 more

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

Science(2021)10.1126/science.abj0299

N/A

0DataRank · unranked

330 citations

Martha Nason, Britta Flach, Matthew Gagné, Sarah O’Connell, Timothy S. Johnston +59 more

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Science Translational Medicine(2021)10.1126/scitranslmed.abi4547

N/A

0DataRank · unranked

74 citations

Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore +55 more

mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates

Nature Immunology(2021)10.1038/s41590-021-01021-0

N/A

0DataRank · unranked

70 citations

Anne P. Werner, Sarah O’ Connell, Matthew Gagné, Lilin Lai, Juan I. Moliva +50 more

Plasmodium falciparum –specific IgM B cells dominate in children, expand with malaria, and produce functional IgM

The Journal of Experimental Medicine(2021)10.1084/jem.20200901

N/A

0DataRank · unranked

66 citations

Padmapriya Sekar, Ababacar Diouf, Kazutoyo Miura, Kristin L. Boswell, Jeff Skinner +19 more

A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2

JCI Insight(2021)10.1172/jci.insight.146316

N/A

0DataRank · unranked

61 citations

Christina Michalski, Sarah O’Connell, Sarah Dada, Sandeep Narpala, Jean Gelinas +18 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base

Cell Reports(2021)10.1016/j.celrep.2021.108937

N/A

0DataRank · unranked

22 citations

Hongying Duan, Cheng Cheng, Christopher A. Gonelli, Li Ou, Kai Xu +24 more

A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation

Vaccine(2021)10.1016/j.vaccine.2021.04.063

N/A

0DataRank · unranked

21 citations

Nicole Cibelli, Jonathan W. Cooper, Haley Fuller, Zachary Schneiderman, Sara Witter +12 more

Why are there so few (or so many) circulating coronaviruses?

Trends in Immunology(2021)10.1016/j.it.2021.07.001

N/A

0DataRank · unranked

12 citations

Daniel C. Douek, Adrian B. McDermott, Bryan T. Grenfell, C. Jessica E. Metcalf, Benjamin L. Rice

Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center

npj Vaccines(2021)10.1038/s41541-020-00277-1

N/A

0DataRank · unranked

5 citations

Constantinos Petrovas, David J. Leggat, Kathryn L. Furr, Michelle A. Lifton, Gail L. Levine +19 more

Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.13.444010

N/A

0DataRank · unranked

54 citations

Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai +27 more

Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.20.440647

N/A

0DataRank · unranked

51 citations

Martha Nason, Britta Flach, Matthew Gagné, Sarah O’ Connell, Timothy S. Johnston +59 more

Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.02.433390

N/A

0DataRank · unranked

36 citations

Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore +53 more

Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.21.445189

N/A

0DataRank · unranked

11 citations

Anne P. Werner, Sarah O’ Connell, Matthew Gagné, Lilin Lai, Juan I. Moliva +48 more

Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.11.456015

N/A

0DataRank · unranked

10 citations

Matthew Gagné, Danielle A. Wagner, Sarah O’ Connell, Sandeep Narpala, Dillon R. Flebbe +60 more

Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2

medRxiv(2021)10.1101/2021.01.05.21249240

N/A

0DataRank · unranked

5 citations

Sarah O’Connell, Tammy Armbrust, Aisha M. Mergaert, Sandeep Narpala, Peter Halfmann +11 more

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

Cell(2022)10.1016/j.cell.2022.03.038

N/A

0DataRank · unranked

228 citations

Juan I. Moliva, Kathryn E. Foulds, Shayne F. Andrew, Barbara J. Flynn, Anne P. Werner +72 more

Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses

Immunity(2022)10.1016/j.immuni.2022.10.015

N/A

0DataRank · unranked

58 citations

Jeffrey C. Boyington, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie, Gabriele Cerutti, Crystal Sao‐Fong Cheung +23 more

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac041

N/A

0DataRank · unranked

36 citations

Nigel Garrett, Edmund V. Capparelli, Farzana Osman, Ishana Harkoo, Nonhlanhla Yende‐Zuma +17 more

Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition

Immunity(2022)10.1016/j.immuni.2022.10.003

N/A

0DataRank · unranked

32 citations

JungHyun Kim, Wei Bu, Nathan L. Board, Yaroslav Tsybovsky, Yanmei Wang +16 more

Early human B cell signatures of the primary antibody response to mRNA vaccination

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2204607119

N/A

0DataRank · unranked

39 citations

Nicholas Rachmaninoff, William W. Lau, Clarisa M. Buckner, Krittin Trihemasava, Jana Blažková +18 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Scientific Reports(2022)10.1038/s41598-022-22435-2

N/A

0DataRank · unranked

14 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

Harnessing low dimensionality to visualize the antibody–virus landscape for influenza

Nature Computational Science(2022)10.1038/s43588-022-00375-1

N/A

0DataRank · unranked

11 citations

Adrian Creanga, Sarah F. Andrews, Adrian B. McDermott, Masaru Kanekiyo, Tal Einav

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.479037

N/A

0DataRank · unranked

51 citations

Juan I. Moliva, Kathryn E. Foulds, Shayne F. Andrew, Barbara J. Flynn, Anne P. Werner +61 more

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.04.06.22272763

N/A

0DataRank · unranked

12 citations

Adrian B. McDermott, David Benkeser, Sanne Roels, Daniel J Stieh, An Vandebosch +56 more

Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.28.486152

N/A

0DataRank · unranked

5 citations

Maryam Musayev, Timothy S. Johnston, Danielle A. Wagner, Amy R. Henry, Lingshu Wang +49 more

Influenza vaccination and single cell multiomics reveal sex dimorphic immune imprints of prior mild COVID-19

medRxiv(2022)10.1101/2022.02.17.22271138

N/A

0DataRank · unranked

2 citations

William W. Lau, Can Liu, Kyu Lee Han, Kiera L. Vrindten, Guangping Sun +22 more

Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.29.485179

N/A

0DataRank · unranked

2 citations

Timothy A. Watkins, Evan M. Cale, Jakob Samsel, Sarah F. Andrews, David R. Ambrozak +18 more

Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination

medRxiv(2022)10.1101/2022.08.30.22279344

N/A

0DataRank · unranked

1 citations

Lela Kardava, Omar El Merhebi, Sandeep Narpala, Leonid Serebryannyy, Bob C. Lin +17 more

Engineering of HIV-1 neutralizing antibody CAP256V2LS for manufacturability and improved half life

Research Square(2022)10.21203/rs.3.rs-1534769/v1

N/A

0DataRank · unranked

0 citations

Deepika Gollapudi, Jason Gorman, Sijy O’Dell, Leland F. Damron, Krisha McKee +23 more

Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection

Neurology Neuroimmunology & Neuroinflammation(2023)10.1212/nxi.0000000000200097

N/A

0DataRank · unranked

54 citations

Yoshimi Enose‐Akahata, Dima A. Hammoud, Anthony J. Videckis, Sandeep Narpala, Sarah O’Connell +12 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Respiratory virus circulation during the first year of the COVID‐19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort

Influenza and Other Respiratory Viruses(2023)10.1111/irv.13106

N/A

0DataRank · unranked

18 citations

Latifa A. Bazzi, Amy P. Callear, Joshua G. Petrie, Ryan E. Malosh, Joshua E Foster-Tucker +7 more

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial

Viruses(2023)10.3390/v15102029

N/A

0DataRank · unranked

17 citations

Nima S. Hejazi, Bryan S. Blette, Lindsay N. Carpp, David Benkeser, David C. Montefiori +38 more

Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization

Journal of Virology(2023)10.1128/jvi.01604-22

N/A

0DataRank · unranked

16 citations

Anita Changela, Jason Gorman, Kai Xu, Gwo‐Yu Chuang, Chen‐Hsiang Shen +33 more

Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes

PLoS Pathogens(2023)10.1371/journal.ppat.1011514

N/A

0DataRank · unranked

12 citations

Mallory L. Myers, Neetu M. Gulati, Madhu Prabhakaran, Joshua Brand, Sarah F. Andrews +10 more

Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad069

N/A

0DataRank · unranked

10 citations

Holly Janes, Eric Chun‐Pu Chu, Lakshmi Jayashankar, Christos J. Petropoulos, Leonid Serebryannyy +19 more

High frequency of HIV precursor-target-specific B cells in sub-Saharan populations

Cell Reports(2023)10.1016/j.celrep.2023.113450

N/A

0DataRank · unranked

4 citations

Alberto Cagigi, Chen‐Hsiang Shen, Amy R. Henry, Timothy S. Johnston, Chaim A. Schramm +15 more

Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humans

STAR Protocols(2023)10.1016/j.xpro.2023.102576

N/A

0DataRank · unranked

3 citations

David J. Leggat, Kristen W. Cohen, Lara Hoeweler, Guacyara C Erwin, Farhard Rahaman +22 more

C1q Enables Influenza HA Stem Binding Antibodies to Block Viral Attachment and Broadens the Antibody Escape Repertoire

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.12.544648

N/A

0DataRank · unranked

1 citations

Jefferson Santos, Matthew Angel, Zhe Hu, Jaroslav Hollý, James S. Gibbs +13 more

Immune memory shapes human polyclonal antibody responses to H2N2 vaccination

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.23.554525

N/A

0DataRank · unranked

0 citations

Julianna Han, Hailee R. Perrett, Sara T. Richey, Abigail M. Jackson, Alesandra J. Rodriguez +12 more

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

UNC Libraries(2023)10.17615/q13b-q658

N/A

0DataRank · unranked

0 citations

Srilatha Edupuganti, Shelly Karuna, Michal Juraska, Nonhlanhla N. Mkhize, P. Andrew +16 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site

Science Immunology(2024)10.1126/sciimmunol.adk9550

N/A

0DataRank · unranked

40 citations

Max Medina-Ramírez, Shiyu Zhang, Sven Kratochvil, Yuejiao Xian, Ja‐Hyun Koo +42 more